MX2010004291A - Producto de dispersion solida de farmacos basados en n-aril urea. - Google Patents
Producto de dispersion solida de farmacos basados en n-aril urea.Info
- Publication number
- MX2010004291A MX2010004291A MX2010004291A MX2010004291A MX2010004291A MX 2010004291 A MX2010004291 A MX 2010004291A MX 2010004291 A MX2010004291 A MX 2010004291A MX 2010004291 A MX2010004291 A MX 2010004291A MX 2010004291 A MX2010004291 A MX 2010004291A
- Authority
- MX
- Mexico
- Prior art keywords
- solid dispersion
- dispersion product
- aryl urea
- based drugs
- solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un producto de dispersión sólida que comprende al menos un agente con actividad farmacéutica basado en N-aril urea que se obtiene mediante a) la preparación de una mezcla líquida que contiene al menos un agente activo, al menos un agente formador de matriz farmacéuticamente aceptable, al menos un agente tensoactivo farmacéuticamente aceptable y al menos un solvente, y b) la eliminación de los uno o más solventes de la mezcla líquida, para obtener el producto de dispersión sólida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99961807P | 2007-10-19 | 2007-10-19 | |
PCT/EP2008/064076 WO2009050291A2 (en) | 2007-10-19 | 2008-10-17 | Solid dispersion product of n-aryl urea-based drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004291A true MX2010004291A (es) | 2010-08-02 |
Family
ID=40089463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004291A MX2010004291A (es) | 2007-10-19 | 2008-10-17 | Producto de dispersion solida de farmacos basados en n-aril urea. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2197425A2 (es) |
JP (1) | JP2011500649A (es) |
KR (1) | KR20100087170A (es) |
CN (1) | CN101827584A (es) |
AU (1) | AU2008313622A1 (es) |
BR (1) | BRPI0818340A2 (es) |
CA (1) | CA2699301A1 (es) |
CO (1) | CO6270206A2 (es) |
CR (1) | CR11442A (es) |
DO (1) | DOP2010000117A (es) |
EC (1) | ECSP10010183A (es) |
GT (1) | GT201000102A (es) |
MX (1) | MX2010004291A (es) |
PA (1) | PA8800101A1 (es) |
RU (1) | RU2010119929A (es) |
UA (1) | UA100865C2 (es) |
WO (1) | WO2009050291A2 (es) |
ZA (1) | ZA201002095B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009100176A2 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
AR077975A1 (es) | 2009-08-28 | 2011-10-05 | Irm Llc | Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina |
MX2012014387A (es) * | 2010-06-09 | 2013-05-01 | Abbvie Inc | Dispersiones solidas que contienen inhibidores de cinasa. |
CA2855243C (en) | 2011-11-11 | 2020-04-14 | Novartis Ag | Method of treating a proliferative disease |
LT2782557T (lt) * | 2011-11-23 | 2018-12-27 | Array Biopharma, Inc. | Farmacinės kompozicijos |
WO2014003677A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
WO2014003678A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070104780A1 (en) * | 2005-10-25 | 2007-05-10 | Lipari John M | Formulation comprising a drug of low water solubility and method of use thereof |
WO2007066189A2 (en) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
EP2089003A1 (en) * | 2006-11-09 | 2009-08-19 | Abbott GmbH & Co. KG | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2008
- 2008-10-17 MX MX2010004291A patent/MX2010004291A/es not_active Application Discontinuation
- 2008-10-17 WO PCT/EP2008/064076 patent/WO2009050291A2/en active Application Filing
- 2008-10-17 AU AU2008313622A patent/AU2008313622A1/en not_active Abandoned
- 2008-10-17 CA CA2699301A patent/CA2699301A1/en not_active Abandoned
- 2008-10-17 KR KR1020107010979A patent/KR20100087170A/ko not_active Application Discontinuation
- 2008-10-17 RU RU2010119929/15A patent/RU2010119929A/ru not_active Application Discontinuation
- 2008-10-17 CN CN200880112150A patent/CN101827584A/zh active Pending
- 2008-10-17 UA UAA201006029A patent/UA100865C2/ru unknown
- 2008-10-17 PA PA20088800101A patent/PA8800101A1/es unknown
- 2008-10-17 EP EP08839333A patent/EP2197425A2/en not_active Withdrawn
- 2008-10-17 BR BRPI0818340 patent/BRPI0818340A2/pt not_active IP Right Cessation
- 2008-10-17 JP JP2010529408A patent/JP2011500649A/ja active Pending
-
2010
- 2010-03-24 ZA ZA2010/02095A patent/ZA201002095B/en unknown
- 2010-04-16 GT GT201000102A patent/GT201000102A/es unknown
- 2010-04-16 DO DO2010000117A patent/DOP2010000117A/es unknown
- 2010-04-27 CO CO10049271A patent/CO6270206A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010183A patent/ECSP10010183A/es unknown
- 2010-05-19 CR CR11442A patent/CR11442A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DOP2010000117A (es) | 2010-05-15 |
WO2009050291A2 (en) | 2009-04-23 |
BRPI0818340A2 (pt) | 2015-04-22 |
UA100865C2 (ru) | 2013-02-11 |
ZA201002095B (en) | 2011-11-30 |
CA2699301A1 (en) | 2009-04-23 |
PA8800101A1 (es) | 2009-05-15 |
JP2011500649A (ja) | 2011-01-06 |
EP2197425A2 (en) | 2010-06-23 |
CO6270206A2 (es) | 2011-04-20 |
CR11442A (es) | 2010-09-06 |
CN101827584A (zh) | 2010-09-08 |
WO2009050291A3 (en) | 2010-04-08 |
RU2010119929A (ru) | 2011-11-27 |
AU2008313622A1 (en) | 2009-04-23 |
KR20100087170A (ko) | 2010-08-03 |
GT201000102A (es) | 2012-03-12 |
ECSP10010183A (es) | 2010-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA100866C2 (ru) | Продукт твердой дисперсии, который содержит соединения на основе n-арилмочевины | |
MX2010004291A (es) | Producto de dispersion solida de farmacos basados en n-aril urea. | |
TW200640502A (en) | Tablets with improved drug substance dispersibility | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
WO2010015567A3 (en) | Controlled release formulations using intelligent polymers | |
WO2010121177A3 (en) | Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses | |
WO2010021607A3 (en) | Pharmaceutical formulation | |
PL2046292T3 (pl) | Preparaty eterów benzymidazolilo-pirydylowych | |
WO2014118808A3 (en) | Ticagrelor solid dispersion | |
WO2009060952A1 (ja) | 新規製剤 | |
MX363699B (es) | Producto de comicronizacion que comprende acetato de ulipristal. | |
MX2015007127A (es) | Dispersion solida de un modulador selectivo de los receptores de progesterona. | |
WO2011076209A3 (en) | Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue | |
WO2012024605A3 (en) | Devices and methods for intravaginal delivery of drugs and other substances | |
WO2012029076A3 (en) | Stable pharmaceutical composition | |
WO2013171766A3 (en) | Saxagliptin solid dispersion | |
WO2010058104A3 (fr) | Compositions pharmaceutiques utilisant l'inuline comme excipient de granulation | |
WO2008129607A1 (ja) | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 | |
TH104743B (th) | ผลิตภัณฑ์แพร่กระจายแข็งที่มีสารประกอบ n-อะริล ยูเรีย | |
WO2012052178A3 (de) | Verbesserte pharmazeutische starterpellets | |
WO2011002424A3 (en) | Solubility and stability enchancing pharmaceutical formulation comprising ezetimibe and simvastatin | |
CO6270249A2 (es) | Fibra, pelicula o espuma que comprende un plastificador y un gel ligado a arcilla cargado y metodos para su produccion | |
MY148088A (en) | Stable nanoparticle formulations | |
TH104743A (th) | ผลิตภัณฑ์แพร่กระจายแข็งที่มีสารประกอบ n-อะริล ยูเรีย | |
WO2011154830A3 (es) | Forma farmaceutica de inhibidores de la fosfodiesterasa para administracion transmucosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |